TSE:MFC

Manulife Financial (MFC.TO)

60.29
-0.38 (0.63%)
as of Jul 23, 2026, 5:23:07 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
TOP PICK
(A Top Pick Jan 14/05. Up 10%.) High returns on investments. Well managed. Growth opportunities around the world.
BUY
Looking at this one very closely. John Hancock acquisition has made it into a world class company.
BUY ON WEAKNESS
Would buy it up to $57. Good dividend. John Hancock acquisition has gone well. Good growth in Asia.
BUY
Likes both Great West Life (GWO-T) and Manulife (MFC-T). Manulife is more international. Both blue chip stocks.
BUY
Favourite insurance company. Has the best management. Likes their international exposure, especially the far east.
BUY
Has been one of his favourites for the past couple of years. Scored very high on his analytical approach of "cash flow return on enterprise value", and continues to score high. John Hancock integration has gone very well.
BUY
His favourite financial stock. Better than the banks. Has the best management in North America. John Hancock merger was excellent. Have a growing exposure in the far east. The company is under leveraged. Expects there will be a major US merger soon.
BUY
One of his favourite financials. Has great exposure overseas which is a terrific growth opportunity. John Hancock was a good acquisition into the US. Probably the best managed insurance company in North America.
TOP PICK
Has marked time on ROE since the Hancock acquisition. The ROE level is now 12% and is starting to rise at a rate which implies that you are going to see more positive earnings surprises going forward. Coming into a period where interest rates are stable to downward and this is an interest sensitive name.
DON'T BUY
Has a model price of $54.33 which is a negative differential of 17%. Could go a little higher, but thinks it's fully valued here.
BUY
Management is particularily driven and feels that the John Hancock acquisition is going to be particularily good.
BUY
Life companies have suffered with all the fears of higher interest rates. His view is that interest rates are not going up so fast or so far as had been thought before and probably all the life companies are pretty good Buys right now including Power Group (POW-T) Sun Life (SLF-T) and Manulife.
BUY
In spite of the threat of higher interest, the financial sector is still good to be in. Extremely well managed. Will do well longer term. Both Sun Life (SLF-T) and ManuLife have lower payout ratios than the banks, so they have opportunities to increase dividends at a faster rate than the banks. Feels that at some point they will acquire a bank, probably Bank of Montreal (BMO-T).
BUY
One of his favourite financials. The integration with John Hancock is supposed expected to be done by October. This acquisition has made them more levered to the US$. Great footprint in Asia, US and Canada.
DON'T BUY
All of the insurance companies are pretty much at the kinds of levels where he doesn't find them attractive to buy. They're at long term highs and he would wait for much better opportunities.
Showing 1,936 to 1,950 of 2,283 entries